research The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
This review highlights that various targeted cancer therapies are associated with specific ocular side-effects, emphasizing the importance of awareness among ophthalmologists for timely diagnosis and management.
